Cargando…

The selective sigma-1 receptor antagonist E-52862 attenuates neuropathic pain of different aetiology in rats

E-52862 is a selective σ(1)R antagonist currently undergoing phase II clinical trials for neuropathic pain and represents a potential first-in-class analgesic. Here, we investigated the effect of single and repeated administration of E-52862 on different pain-related behaviours in several neuropathi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gris, Georgia, Portillo-Salido, Enrique, Aubel, Bertrand, Darbaky, Yassine, Deseure, Kristof, Vela, José Miguel, Merlos, Manuel, Zamanillo, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4834548/ https://www.ncbi.nlm.nih.gov/pubmed/27087602 http://dx.doi.org/10.1038/srep24591

Ejemplares similares

Repeated Sigma-1 Receptor Antagonist MR309 Administration Modulates Central Neuropathic Pain Development After Spinal Cord Injury in Mice
por: Castany, Sílvia, et al.
Publicado: (2019)

Pharmacological sensitivity of reflexive and nonreflexive outcomes as a correlate of the sensory and affective responses to visceral pain in mice
por: de la Puente, Beatriz, et al.
Publicado: (2017)

Changes in saccharin preference behavior as a primary outcome to evaluate pain and analgesia in acetic acid-induced visceral pain in mice
por: de la Puente, Beatriz, et al.
Publicado: (2015)

Critical role of sigma-1 receptors in central neuropathic pain-related behaviours after mild spinal cord injury in mice
por: Castany, Sílvia, et al.
Publicado: (2018)

Neuroprotective Effects of Sigma 1 Receptor Ligands on Motoneuron Death after Spinal Root Injury in Mice
por: Gaja-Capdevila, Núria, et al.
Publicado: (2021)

Bispecific sigma-1 receptor antagonism and mu-opioid receptor partial agonism: WLB-73502, an analgesic with improved efficacy and safety profile compared to strong opioids
por: Vidal-Torres, Alba, et al.
Publicado: (2023)

Trends in Sigma-1 Receptor Research: A 25-Year Bibliometric Analysis
por: Romero, Luz, et al.
Publicado: (2019)

Long-Lasting Nociplastic Pain Modulation by Repeated Administration of Sigma-1 Receptor Antagonist BD1063 in Fibromyalgia-like Mouse Models
por: Álvarez-Pérez, Beltrán, et al.
Publicado: (2022)

Blockade of the Sigma-1 Receptor Relieves Cognitive and Emotional Impairments Associated to Chronic Osteoarthritis Pain
por: Carcolé, Mireia, et al.
Publicado: (2019)

Differential drug effects on spontaneous and evoked pain behavior in a model of trigeminal neuropathic pain
por: Deseure, K, et al.
Publicado: (2017)

The Sigma-1 Receptor Antagonist, S1RA, Reduces Stroke Damage, Ameliorates Post-Stroke Neurological Deficits and Suppresses the Overexpression of MMP-9
por: Sánchez-Blázquez, Pilar, et al.
Publicado: (2017)

Blockade of sigma 1 receptors alleviates sensory signs of diabetic neuropathy in rats
por: Paniagua, N., et al.
Publicado: (2016)

Antagonism of Transient Receptor Potential Ankyrin Type-1 Channels as a Potential Target for the Treatment of Trigeminal Neuropathic Pain: Study in an Animal Model
por: Demartini, Chiara, et al.
Publicado: (2018)

Supraspinal and Peripheral, but Not Intrathecal, σ(1)R Blockade by S1RA Enhances Morphine Antinociception
por: Vidal-Torres, Alba, et al.
Publicado: (2019)

The role of shear stress in the aetiology of diabetic neuropathic foot ulcers
por: Giacomozzi, C, et al.
Publicado: (2008)

The Sigma 2 receptor promotes and the Sigma 1 receptor inhibits mu-opioid receptor-mediated antinociception
por: Sánchez-Blázquez, Pilar, et al.
Publicado: (2020)

Discovery of RC-752, a Novel Sigma-1 Receptor Antagonist with Antinociceptive Activity: A Promising Tool for Fighting Neuropathic Pain
por: Rossino, Giacomo, et al.
Publicado: (2023)

Genomic Action of Sigma-1 Receptor Chaperone Relates to Neuropathic Pain
por: Wang, Shao-Ming, et al.
Publicado: (2021)

Altered sensitivity to mechanical stimulation during prolonged subcutaneous administration of endothelin-1 in rats
por: Hans, Guy, et al.
Publicado: (2009)

Genetic inactivation and pharmacological blockade of sigma-1 receptors prevent paclitaxel-induced sensory-nerve mitochondrial abnormalities and neuropathic pain in mice
por: Nieto, Francisco R, et al.
Publicado: (2014)

Correction to: Genomic Action of Sigma-1 Receptor Chaperone Relates to Neuropathic Pain
por: Wang, Shao-Ming, et al.
Publicado: (2021)

EST79232 and EST79376, Two Novel Sigma-1 Receptor Ligands, Exert Neuroprotection on Models of Motoneuron Degeneration
por: Gaja-Capdevila, Núria, et al.
Publicado: (2022)

Single Doses up to 800 mg of E-52862 Do Not Prolong the QTc Interval – A Retrospective Validation by Pharmacokinetic-Pharmacodynamic Modelling of Electrocardiography Data Utilising the Effects of a Meal on QTc to Demonstrate ECG Assay Sensitivity
por: Täubel, Jörg, et al.
Publicado: (2015)

Modulation by Sigma-1 Receptor of Morphine Analgesia and Tolerance: Nociceptive Pain, Tactile Allodynia and Grip Strength Deficits During Joint Inflammation
por: Montilla-García, Ángeles, et al.
Publicado: (2019)

Genetic and Pharmacological Blockade of Sigma-1 Receptors Attenuates Inflammation-Associated Hypersensitivity during Acute Colitis in CD1 Mice
por: López-Estévez, Sergio, et al.
Publicado: (2023)

“Bedside-to-Bench” Behavioral Outcomes in Animal Models of Pain: Beyond the Evaluation of Reflexes
por: Cobos, Enrique J, et al.
Publicado: (2013)

Repurposing Sigma-1 Receptor Ligands for COVID-19 Therapy?
por: Vela, José Miguel
Publicado: (2020)

Dual Piperidine-Based Histamine H(3) and Sigma-1 Receptor Ligands in the Treatment of Nociceptive and Neuropathic Pain
por: Szczepańska, Katarzyna, et al.
Publicado: (2023)

Sigma-1 Receptor Inhibition Reduces Neuropathic Pain Induced by Partial Sciatic Nerve Transection in Mice by Opioid-Dependent and -Independent Mechanisms
por: Bravo-Caparrós, Inmaculada, et al.
Publicado: (2019)

Cerebral Activation during Von Frey Filament Stimulation in Subjects with Endothelin-1-Induced Mechanical Hyperalgesia: A Functional MRI Study
por: Hans, Guy H., et al.
Publicado: (2013)

A TRPA1 antagonist reverts oxaliplatin-induced neuropathic pain
por: Nativi, Cristina, et al.
Publicado: (2013)

Ligands Exert Biased Activity to Regulate Sigma 1 Receptor Interactions With Cationic TRPA1, TRPV1, and TRPM8 Channels
por: Cortés-Montero, Elsa, et al.
Publicado: (2019)

Editorial: Sigma Receptors
por: Aydar, Ebru, et al.
Publicado: (2020)

Sigma 1 Receptor Antagonists Inhibit Manic-Like Behaviors in Two Congenital Strains of Mice
por: Sánchez-Blázquez, Pilar, et al.
Publicado: (2018)

Inhibitory Effects of Sigma-2 Receptor Agonists on T Lymphocyte Activation
por: Iñiguez, Miguel A., et al.
Publicado: (2013)

Characterization of CM-398, a Novel Selective Sigma-2 Receptor Ligand, as a Potential Therapeutic for Neuropathic Pain
por: Wilson, Lisa L., et al.
Publicado: (2022)

On the width of SIGMA hypernuclei and SIGMA- atoms
por: Brockmann, R, et al.
Publicado: (1982)

Sum rules for $\SIGMA\SIGMA$ (In Russian)
por: Fil'kov, L V, et al.
Publicado: (1970)

On the aetiology of autism
por: Cannell, John J
Publicado: (2010)

The Ætiology of Cancer
Publicado: (1899)

Cannot write session to /tmp/vufind_sessions/sess_t6jhr2mjvhmqp8h09v5poos2j1